Institutional investors purchased a net $519.8 thousand shares of TARO during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 12.05% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 65.5 Thousand shares of Taro Pharmaceutical Indus...